AETHLON MEDICAL, INC. Operating Lease Cost
AETHLON MEDICAL, INC. (AEMD) reported Operating Lease Cost of $68.86 thousand for the 9-month period ending 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2020-02-10
- AETHLON MEDICAL, INC. operating lease, cost for the quarter ending 2019-12-31 was $23.18K.
- AETHLON MEDICAL, INC. operating lease, cost for the quarter ending 2019-09-30 was $22.95K.
- AETHLON MEDICAL, INC. operating lease, cost for the quarter ending 2019-06-30 was $22.73K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month |
|---|---|---|---|
| 2019-12-31 | $23.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $46.13K derived: sum of 2 quarters · filed 2020-02-10 | $68.86K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $22.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-01 | $45.68K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $22.73K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |